PubMed · 12237435
Lymphoid activation: a confounding factor in AIDS vaccine development?
Abstract
In a previous vaccination trial, inoculation of env gene DNA failed to elicit a detectable antibody response, yet accelerated virus dissemination in most immunized cats following challenge with feline immunodeficiency virus. This result raised the possibility that cell-mediated immune responses had given rise to immune-mediated enhancement of infection. Since high-level replication of immunodeficiency viruses in lymphocytes requires cellular activation, antigen-specific responses or non-specific polyclonal activation may have increased the frequency of optimal target cells. In the present DNA vaccination trial, although designed so as to minimize non-specific polyclonal activation, immune-mediated enhancement was nonetheless observed in certain immunized cats. Moreover, rapid virus dissemination in vivo was associated with the presence of T-helper responses prior to challenge, and was linked to increased susceptibility of lymphocytes to ex vivo infection. Immune activation may thus be a confounding factor in vaccination against lentivirus infection, diminishing vaccine efficacy and giving rise to immune-mediated enhancement.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jennifer Richardson, Sophie Broche, Sandrine Baud, Thierry Leste-Lasserre, Françoise Féménia, Daniel Levy, Anne Moraillon, Gianfranco Pancino, Pierre Sonigo. 2002. Lymphoid activation: a confounding factor in AIDS vaccine development?. https://doi.org/10.1099/0022-1317-83-10-2515
Cite the original work for its findings. Save a collection to share your selection of sources.